Extracorporeal Shock wave Lithotripsy (ESWL) was first introduced by Chaussy and his co-workers in 1980 and was approved by FDA in 1984. 1,2 Since then ESWL dramatically changed the management of renal and ureteric calculus disease. Now ESWL represents the first line therapy for the majority of urinary tract calculi. It is a simple and safe technique in which renal and ureteric calculi are pulverized into small fragments by shockwaves and then allowed to pass spontaneously in small fragments along with urine.
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Methods:
This is a prospective observational study performed in Pokhara Kidney Stone Centre and Manipal Teaching Hospital in 112 cases undergoing elective ESWL for solitary renal stones, stones in the Pelvi-ureteric junction, ureter and vesico-ureteric junction from August 2010 to August 2011. Cases with multiple calculi and calculus in the mid-ureter region were excluded from the study. All patients underwent X-ray of kidney, ureter and bladder (KUB) for visualization of stones. IVU (Intravenous Urography) and USG-KUB was ordered according to the individual need. The size and position were confirmed by a consultant radiologist.
All patients were treated with Allenger's UROLITH+ ESWL Machine targeted under C-Arm Image Intensifier. All patients were given intravenous antibiotic (Gentamycin) and intramuscular diclofenac half an hour before the procedure. After the session patient were given antibiotics and analgesics for 5 days. Patient were observed in the centre for one hour for any immediate complications and then at 7 th day with X-ray KUB for clearance of the stone and residual fragments. Follow up was continued for next 4 weeks till complete clearance of the stone or failure to disintegrate. In case of failure to disintegrate, patients were subjected for repeat session of ESWL. The gap between two sessions was 1 month and in case no fragmentation was seen even on multiple sessions, patients were advised for other surgical remedies and were excluded from the study.
Informed consent was taken from all the patients and any patients not willing for repeat sessions of ESWL on failure of disintegration at any sessions, despite the treating surgeon's advice, were also excluded from the study. Data was collected on location and size of the stones and was compared with sessions of ESWL required for successful fragmentation of the stones as outcome measures. One Way ANOVA was used to compare means of various variables of location and size. Statistical analysis was done using SPSS 11.5 software.
Results:
Over a period of 1 year, we had 123 cases of urolithiasis undergoing elective ESWL out of which 13 cases had failed to disintegrate completely. Such patients were advised to abandon ESWL and go for other surgical procedures either open surgery, PCNL (Per-cutaneous Nephrolithotomy) or endourological procedure and were excluded from the study. Thus, there were altogether 112 cases included in this study. Of the 112 cases, 61 (54.5%) had stones on the left side and 51 (45.5%) had stones at the right side. The mean age of the patients was 36.09 years ranging from 16 to 89. There were 69 males and 43 females with male to female ratio as 1.6:1. Table 1 shows the age distribution of the patients undergoing ESWL. Similarly, when analyzed according to the various size, stones less than 10 mm required 1.18 mean numbers of sessions whereas those between 10.1-20 mm required 1.26 mean sessions and those more than 20 mm required almost 3.4 mean number of sessions for complete fragmentation ( F= 50.24, P=<0.0001) ( Table 3) . 
Discussion:
Before the advent of ESWL and other minimal invasive procedures like ureterorenoscopy and PCNL, open surgery represented the treatment of choice for most renal and ureteric stones. At present era ESWL has been established as the treatment of choice for most of the renal and ureteric calculi due to its noninvasive character, favorable clinical outcome, low complication rate and only a few absolute contraindications (e.g., pregnancy or aortic aneurysms). 3 However, not all kidney stones are amenable to treatment by ESWL. The success rate of ESWL depends upon various factors like stone size and burden, stone density and composition, location of the stone, renal morphology, congenital anomalies etc. 4, 5 Therefore it is very important to estimate the probability of stone clearance for each individual so as to determine who will experience maximum benefit from ESWL.
In our study we had included and studied various aspects of only those cases that had completed ESWL successfully. There were also 11 cases that were refractory to ESWL and required some form of surgical procedures. Thus the success rate in our series was 91.1%. No other form of ancillary procedures like DJ stenting was required in our series. This could be because there were only 5 cases of stones which was more than 20 mm and that we had excluded multiple stones, stones in the mid ureter and completely refractory stones which has less chances of disintegration with ESWL. Various studies have reported success rate between 78-86.7% for renal and 84.2-88.7% for ureteric stones. [4] [5] [6] [7] A recent study in Katmandu suggested 96 % success for solitary stones at 6 weeks which is almost comparable to our result. 8 In our study, Size of the stone was one of the most important factors determining success of ESWL. The mean number of sessions required for successful fragmentation of the stones increased with increase in size. Stones less than 10 mm required 1.18 mean sessions, 10.1-20 mm stones required 1.26 mean sessions and stones more than 20mm required 3.4 mean sessions for successful fragmentation (P<0.001). Lingeman et al described size of the stone as one of the most important factor determining success of ESWL. 9 Newman D et al in their series of 1910 cases found than success rate was 80% with 0-10 mm stones whereas it declined to 60% with size of the stone greater than 30 mm. 10 Lalaket al. in their series of 500 cases reported that overall stone-free rate was 76%, 66% and 47% for stones of size <10mm, 10-20mm and > 20 mm respectively. 11 Similarly Abdel-Khalek et al reported stone free rate as 89.7%for stones <15 mm and 78% for stones >15 mm(p<0.0001). 5 All these authors were of common opinion that size of th0e stone was one of the most important predictive factor for successful outcome of ESWL.
Location of stone is also very important point to consider while treating a patient with urinary stone disease. For renal stones studies suggest that lower pole has got lesser rates of clearance than upper and mid pole. Although, the disintegration rate of lower calyx stones does not differ much than that of stones in other localizations, the clearance of the fragments is not as similar due to the unfavorable spatial anatomy of the lower pole collectingsystem. 12 Preminger GM et al in their article mention that clearance rate for ureteric stone located at upper, mid and distal ureter were82%, 73% and 74% respectively. 13 Delakas etal. declared distal ureteric stones and stones >10mm to be the strongest independent predictors of failure of ESWL in ureteric stones. 14 In our series we found not much difference in the mean number of sessions between the various location of urinary tract for complete fragmentation and clearance of stones. The mean number of sessions required ranged from 1 in VUJ and 1.71 in lower ureter.
Altogether 28 (25%) cases had complications in our series and not a single incidence of any serious complications was recorded. Urinary tract infection was seen in 14 (12.5%) cases, ureteric colic in 11 (9.8%) and flank pain with bruise in 6 (5.3 %) of cases. All cases were managed conservatively. Various complications have been reported after ESWL in many series including, UTI and urosepsis, mild and frank hematuria, flank pain and bruises, anuria, steinstrasse etc.
